News

Teams from Bedfont® and Perrys Chartered Accountants to go head-to-head in fundraising event. Bedfont® Scientific Limited, a local MedTech company with over 48 years of knowledge and expertise in designing and manufacturing medical breath analysis devices, is proud to participate...

Fractional exhaled Nitric Oxide (FeNO) is extensively utilised in both primary and secondary care settings worldwide. Many regions recommend FeNO-guided management as part of their clinical protocols. This article reviews FeNO-related guidelines in the UK and internationally, with a focus...

HMBT World Digestive Health Day (WDHD) is observed annually on May 29 . Established in 2004, the day commemorates the founding of the World Gastroenterology Organization (WGO) in 1958.WDHD aims to raise global awareness about the prevention, prevalence, diagnosis, management,...

Bedfont® Scientific Limited iCOquit® Smokerlyzer® features in award winning app to aid in smoking cessation. Erika Bloom, Ph.D., Director of Product and Research at WayBetter, won the Digital Health Tech Madness Champion Award at the Society of Behavioral Medicine’s (SBM)...

Families and four-legged friends walked among the bluebells to make a difference for Heart of Kent Hospice. On Sunday, May 4th, Bedfont® teamed up with joint headline sponsors NewMed Limited and participated in this year's Bluebell Walk, hosted by Heart...

The latest UK asthma guidelines1 have identified how Fractional exhaled Nitric Oxide (FeNO) testing fits into the diagnosis and ongoing management of asthma. The guidelines are based on the latest clinical evidence, cost-effectiveness, and cost-effective modelling, so they are strongly...